yingweiwo

Aurora Kinase

Aurora Kinase

The Aurora kinases comprise a family of evolutionary conserved serine/threonine kinases (Aurora-A, Aurora-B, and Aurora-C).Aurora kinases regulate a variety of cell cycle-related processes and are necessary for the assembly and operation of the bipolar spindle during the mitotic and meiotic phases.

While Aurora-A, Aurora-B, and Aurora-C have very similar subcellular localizations and functions during mitosis, they also share a highly conserved kinase domain. While Aurora-B and Aurora-C are necessary for condensation, attachment to kinetochores, and alignment of chromosomes during (pro-)metaphase and cytokinesis, Aurora-A primarily regulates centrosome maturation and bipolar spindle assembly. All Aurora kinase members play oncogenic roles related to their mitotic activity and support the survival and growth of cancer cells in human tumors. Researchers studying cancer have become interested in inhibitors that target Aurora kinases.

Aurora Kinase related products

Structure Cat No. Product Name CAS No. Product Description
Cenisertib benzoate V94934 Cenisertib benzoate 1145859-64-8 Cenisertib (AS-703569) benzoate is an ATP-competitive multikinase inhibitor that inhibits the activities of Aurora-kinase-A/B, ABL1, AKT, STAT5, and FLT3.
DBPR728 V88589 DBPR728 2702965-64-6 DBPR728 is an acyl prodrug of 6K465 that carries fewer hydrogen bond donors.
FAK-IN-22 V104462 FAK-IN-22 2703920-02-7 FAK-IN-22 (Compound 26) is an inhibitor of FAK, JAK3, and Aurora B with IC50 values of 50.94 nM, 9.99 nM, and 0.49 nM, respectively, and can effectively inhibit the tumorigenesis and metastasis of pancreatic ductal adenocarcinoma (PDAC).
FAK/aurora kinase-IN-1 V84552 FAK/aurora kinase-IN-1 2178117-69-4
GW814408X V103749 GW814408X 886599-05-9 GW814408X is a kinase chemical genetic group (KCGS) compound that inhibits AURKC kinases involved in cell cycle progression, checkpoint regulation, and cell division.
JB170 V51923 JB170 2705844-82-0 JB170 is a potent and specific PROTAC-mediated degrader of AURORA-A (DC50=28 nM) formed by linking Alisertib to the Cereblon ligand Thalidomide.
MLN8054 sodium V94222 MLN8054 sodium 869366-15-4 MLN8054 sodium is an Aurora A inhibitor with radiosensitizing effects.
Phthalazinone pyrazole V4347 Phthalazinone pyrazole 880487-62-7 Phthalazinone pyrazole is a potent, selective, orally bioactive Aurora-Kinase inhibitor (antagonist) with IC50 of 0.031 μM.
PROTAC MPS1 degrader 1 V94063 PROTAC MPS1 degrader 1 PROTAC MPS1 degrader 1 (compound 19) is a potent degrader of monopolar spindle 1 (Mps1, TTK), AURKA, and AURKB with DC50 of 17.7, 108.7, and 570.3 nM, respectively.
PROTAC MPS1 degrader 2 V94065 PROTAC MPS1 degrader 2 PROTAC MPS1 degrader 2 (compound 15) is a potent degrader of monopolar spindle 1 (Mps1, TTK), AURKA, and AURKB with DC50 of 42.0, 2.1, and 154.0 nM, respectively.
SCH-1473759 V4666 SCH-1473759 1094069-99-4 SCH-1473759 (SCH1473759) is a novel, potent and selective aurora inhibitor with anticancer effects.
SP-96 V35264 SP-96 2682114-54-9 SP-96 is a specific and ATP-competitive Aurora B inhibitor (antagonist) with IC50 of 0.316 nM and >2000-fold selectivity for FLT3 and KIT.
TAK-901 hydrochloride V88593 TAK-901 hydrochloride 934542-50-4 TAK-901 hydrochloride is a multi-target aurora kinase inhibitor with IC50 values of 21 and 15 nM for aurora kinase A and B, respectively.
Tenacigenin B V55050 Tenacienin B 80508-42-5 Tenacigenin B is a steroid extracted from Alocasia.
Tinengotinib (TT 00420) V55051 Tinengotinib (TT 00420) 2230490-29-4 Tinengotinib is a modulator of one or more protein kinases, such as Aurora kinase and VEGFR kinase.
Tripolin A ((E)-Tripolin A) V35166 Tripolin A ((E)-Tripolin A) 1148118-92-6 Tripolin A ((E)-Tripolin A) is a specific, non-ATP competitive Aurora A kinase inhibitor (antagonist) with IC50s of 1.5 μM and 7 μM for Aurora A and Aurora B, respectively.
Tripolin B V88596 Tripolin B 186611-44-9 Tripolin B is an ATP-competitive Aurora kinase inhibitor with IC50 values of 2.5 µM and 6 µM for Aurora A and Aurora B kinases, respectively.
TY-011 V98046 TY-011 1389439-77-3 TY-011 is an Aurora A/B kinase inhibitor.
YM-08 V73175 YM-08 812647-88-4 YM-08 (Compounds 7a) is an inhibitor (blocker/antagonist) of SIRT2 that can penetrate the BBB (blood-brain barrier), with IC50 of 19.9 μM.
依罗拉塞替 V4411 Ilorasertib 1227939-82-3 Ilorasertib (also known as ABT-348) is a potent, novel, orally bioavailable and ATP-competitive multi-kinase inhibitor withIC50s for inhibiting binding Aurora B (7 nM), C (1 nM), and A (120 nM), and also inhibits RET tyrosine kinase, PDGFRβ, and Flt1 withIC50s of 7 nM, 3 nM and 32 nM.
Contact Us